Expensify, Inc.
NASDAQ:EXFYSoftware - Application
+$0.35 today
- Market cap
- $157.19M
- Beta
- 1.80
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.22
Volume 0.63M
Average 0.79M
EXFY Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Expensify, Inc.NASDAQ: EXFY
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables broadly unchanged from a year ago
Net receivables stood at $12.99M at the end of Q1 FY2026, up 1.3% from a year earlier and down 0.9% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.
Context
- Net receivables amounted to 6.8% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Net receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +1.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 13.11M USD
- Year-over-year change
- -0.1%
- 4-year CAGR
- -11.3%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.11M | -0.1% |
| FY2024 | 2024-12-31 | 13.13M | -22.0% |
| FY2023 | 2023-12-31 | 16.83M | -11.1% |
| FY2022 | 2022-12-31 | 18.92M | -10.5% |
| FY2021 | 2021-12-31 | 21.15M | — |
Net Receivables vs competitors
How EXFY compares with its peers on the latest reported figures
- EXFY's Mar 2026 net receivables of $12.99M is the 6th highest of the 10 companies compared; the peer median is $21.85M.
- Its year-over-year change of +1.3% is the 5th highest of 10, against a peer median of -13.9%.
- Net receivables amounts to 6.8% of total assets for EXFY, versus a peer median of 20.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $5.38B | +193217.9% | +56.9% | 28.1% | |
TEADTeads Holding Co. | Mar 2026 | $278.78M | -15.1% | +23.6% | 23.2% |
| Mar 2026 | $146.23M | +11.4% | +20.3% | 33.3% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | $22.52M | +7.8% | +16.5% | 20.2% |
| Mar 2026 | $21.85M | -25.9% | -2.6% | 17.4% | |
| Mar 2026 | $12.99M | +1.3% | -11.5% | 6.8% | |
HITHealth In Tech, Inc. | Mar 2026 | $8.9M | +45.9% | +72.8% | 30.7% |
| Dec 2025 | $7.29M | -48.4% | -4.8% | 10.6% | |
| Mar 2026 | $4.75M | -25.3% | -21.4% | 6.5% | |
| Mar 2026 | $3M | -13.9% | +57.5% | 2.8% | |
| Peer median (excluding EXFY) | $21.85M | -13.9% | +20.3% | 20.2% | |
Competitors are the stored peer set for EXFY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 98.4M | 103.79M | 47.51M | 48.77M | 63.08M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 21.15M | 18.92M | 16.83M | 13.13M | 13.11M |
| Inventory | 0 | 8.83M | 0 | 0 | 0 |
| Other Current Assets | 30.66M | 46.76M | 67.25M | 62.89M | 71.23M |
| Total Current Assets | 157.64M | 187.12M | 137.23M | 136.88M | 153.01M |
| Property, Plant & Equipment (Net) | 18.13M | 15.24M | 20.81M | 19.06M | 17.75M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.36M | 6.88M | 12.49M | 16.23M | 13.6M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 370K | 344K | 457K | 499K | 494K |
| Other Non-current Assets | 710K | 664K | 5.79M | 1.01M | 1.15M |
| Total Non-current Assets | 25.57M | 23.13M | 39.55M | 36.8M | 32.98M |
| Total Assets | 183.21M | 210.24M | 176.78M | 173.68M | 185.99M |
| Account Payables | 3.75M | 1.06M | 1.43M | 196K | 289K |
| Short-term Debt | 15.55M | 15.55M | 22.66M | 0 | 0 |
| Tax Payables | 4.94M | 2.72M | 3.39M | 3.47M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24.58M | 42.76M | 43.18M | 29.86M | 29.79M |
| Total Current Liabilities | 53.58M | 60.36M | 67.89M | 38.01M | 46.41M |
| Long-term Debt | 52.07M | 51.43M | 0 | 0 | 5.06M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 153K | 1.2M | 1.68M | 1.69M | 1.78M |
| Total Non-current Liabilities | 53.02M | 52.64M | 8.15M | 7.43M | 6.84M |
| Total Liabilities | 106.6M | 113M | 76.04M | 45.44M | 53.24M |
| Common Stock | 6K | 7K | 8K | 9K | 9K |
| Retained Earnings | (65.91M) | (97.57M) | (140.77M) | (150.83M) | (172.22M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 76.62M | 97.24M | 100.74M | 128.24M | 132.75M |
| Total Debt | 69.97M | 67.79M | 29.55M | 6.47M | 5.74M |
| Net Debt | (28.43M) | (36M) | (17.96M) | (42.31M) | (57.34M) |
Expensify, Inc.
NASDAQ:EXFY
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.